danazol,momelotinib
sierra oncology
['momelotinib', '#mpn', 'momentum', 'mpnsm']
#asco22 #mpnsm mesa: momentum momelotinib vs danazol in mf w anemia prev treated w jaki. mo is a jak1/2 and acvr1 inhibitor (latter activity decreases hepcidin and improves eythropoiesis). crossover permitted on study after week 24. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)